[Skip to Content]
[Skip to Content Landing]
Article
September 8, 1956

COUNCIL ON PHARMACY AND CHEMISTRY

JAMA. 1956;162(2):115-117. doi:10.1001/jama.1956.02970190031008

Preparations for use as stated for the foregoing drug are marketed under the following name: Poliomyelitis Vaccine.

Eli Lilly and Company; Pitman-Moore Company, Division of Allied Laboratories, Inc.; Merck Sharp & Dohme, Division of Merck & Co., Inc.; Wyeth Laboratories, Division of American Home Products Corporation; Public Health Service, U. S. Department of Health, Education and Welfare; Dr. Jonas E. Salk; and Dr. Herbert Ratner cooperated by furnishing scientific data to aid in the evaluation of poliomyelitis vaccine.

First Page Preview View Large
First page PDF preview
First page PDF preview
×